GCC Cancer Hormone Therapy Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. GCC Cancer Hormone Therapy Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. GCC Cancer Hormone Therapy Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. GCC Cancer Hormone Therapy Market Regional Analysis

6.2 GCC Cancer Hormone Therapy Market Revenue 2021-2031 (US$ Million)

6.3 GCC Cancer Hormone Therapy Market Forecast Analysis

7. GCC Cancer Hormone Therapy Market Analysis – by Drug Class

7.1 GnRH Analogs

7.1.1 Overview
7.1.2 GnRH Analogs: GCC Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.2 GnRH Antagonists

7.2.1 Overview
7.2.2 GnRH Antagonists: GCC Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.3 Androgen Receptor Antagonists

7.3.1 Overview
7.3.2 Androgen Receptor Antagonists: GCC Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.4 Aromatase Inhibitors

7.4.1 Overview
7.4.2 Aromatase Inhibitors: GCC Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.5 Selective Estrogen Receptor Modulators

7.5.1 Overview
7.5.2 Selective Estrogen Receptor Modulators: GCC Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.6 Estrogen Receptor Antagonists

7.6.1 Overview
7.6.2 Estrogen Receptor Antagonists: GCC Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.7 Thyroid Hormone Therapy

7.7.1 Overview
7.7.2 Thyroid Hormone Therapy: GCC Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.8 Other Drug Classes

7.8.1 Overview
7.8.2 Other Drug Classes: GCC Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

8. GCC Cancer Hormone Therapy Market Analysis – by Cancer Type

8.1 Breast Cancer

8.1.1 Overview
8.1.2 Breast Cancer: GCC Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

8.2 Prostate Cancer

8.2.1 Overview
8.2.2 Prostate Cancer: GCC Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

8.3 Endometrial Cancer

8.3.1 Overview
8.3.2 Endometrial Cancer: GCC Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

8.4 Ovarian Cancer

8.4.1 Overview
8.4.2 Ovarian Cancer: GCC Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

8.5 Thyroid Cancer

8.5.1 Overview
8.5.2 Thyroid Cancer: GCC Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

8.6 Other Cancer Types

8.6.1 Overview
8.6.2 Other Cancer Types: GCC Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

9. GCC Cancer Hormone Therapy Market Analysis – by Route of Administration

9.1 Oral

9.1.1 Overview
9.1.2 Oral: GCC Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

9.2 Injectable

9.2.1 Overview
9.2.2 Injectable: GCC Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

9.3 Implantable

9.3.1 Overview
9.3.2 Implantable: GCC Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

10. GCC Cancer Hormone Therapy Market Analysis – by Sales Channel

10.1 Hospitals

10.1.1 Overview
10.1.2 Hospitals: GCC Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

10.2 Cancer Treatment Centers

10.2.1 Overview
10.2.2 Cancer Treatment Centers: GCC Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

10.3 Specialty Clinics

10.3.1 Overview
10.3.2 Specialty Clinics: GCC Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

10.4 Retail Pharmacies

10.4.1 Overview
10.4.2 Retail Pharmacies: GCC Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

11. GCC Cancer Hormone Therapy Market – GCC Analysis

11.1 Overview

11.2 GCC

11.2.1 GCC Cancer Hormone Therapy Market Breakdown, by Key Country, 2025 and 2031 (%)
11.2.1.1 GCC Cancer Hormone Therapy Market – Revenue and Forecast Analysis – by Country
11.2.1.1 UAE: GCC Cancer Hormone Therapy Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.1.1 UAE: GCC Cancer Hormone Therapy Market Breakdown, by Drug Class
11.2.1.1.2 UAE: GCC Cancer Hormone Therapy Market Breakdown, by Cancer Type
11.2.1.1.3 UAE: GCC Cancer Hormone Therapy Market Breakdown, by Route of Administration
11.2.1.1.4 UAE: GCC Cancer Hormone Therapy Market Breakdown, by Sales Channel

11.2.1.2 Bahrain: GCC Cancer Hormone Therapy Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.2.1 Bahrain: GCC Cancer Hormone Therapy Market Breakdown, by Drug Class
11.2.1.2.2 Bahrain: GCC Cancer Hormone Therapy Market Breakdown, by Cancer Type
11.2.1.2.3 Bahrain: GCC Cancer Hormone Therapy Market Breakdown, by Route of Administration
11.2.1.2.4 Bahrain: GCC Cancer Hormone Therapy Market Breakdown, by Sales Channel

11.2.1.3 Saudi Arabia: GCC Cancer Hormone Therapy Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.3.1 Saudi Arabia: GCC Cancer Hormone Therapy Market Breakdown, by Drug Class
11.2.1.3.2 Saudi Arabia: GCC Cancer Hormone Therapy Market Breakdown, by Cancer Type
11.2.1.3.3 Saudi Arabia: GCC Cancer Hormone Therapy Market Breakdown, by Route of Administration
11.2.1.3.4 Saudi Arabia: GCC Cancer Hormone Therapy Market Breakdown, by Sales Channel

11.2.1.4 Oman: GCC Cancer Hormone Therapy Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.4.1 Oman: GCC Cancer Hormone Therapy Market Breakdown, by Drug Class
11.2.1.4.2 Oman: GCC Cancer Hormone Therapy Market Breakdown, by Cancer Type
11.2.1.4.3 Oman: GCC Cancer Hormone Therapy Market Breakdown, by Route of Administration
11.2.1.4.4 Oman: GCC Cancer Hormone Therapy Market Breakdown, by Sales Channel

11.2.1.5 Qatar: GCC Cancer Hormone Therapy Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.5.1 Qatar: GCC Cancer Hormone Therapy Market Breakdown, by Drug Class
11.2.1.5.2 Qatar: GCC Cancer Hormone Therapy Market Breakdown, by Cancer Type
11.2.1.5.3 Qatar: GCC Cancer Hormone Therapy Market Breakdown, by Route of Administration
11.2.1.5.4 Qatar: GCC Cancer Hormone Therapy Market Breakdown, by Sales Channel

11.2.1.6 Kuwait: GCC Cancer Hormone Therapy Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.6.1 Kuwait: GCC Cancer Hormone Therapy Market Breakdown, by Drug Class
11.2.1.6.2 Kuwait: GCC Cancer Hormone Therapy Market Breakdown, by Cancer Type
11.2.1.6.3 Kuwait: GCC Cancer Hormone Therapy Market Breakdown, by Route of Administration
11.2.1.6.4 Kuwait: GCC Cancer Hormone Therapy Market Breakdown, by Sales Channel

12. Competitive Landscape

12.1 Heat Map Analysis

12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview

13.2 Market Initiative

13.3 Partnerships and Collaborations

13.4 Other Developments

14. Company Profiles

14.1 Pfizer Inc

14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments

14.2 AbbVie

14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments

14.3 Johnson & Johnson

14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments

14.4 Novartis AG

14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments

14.5 AstraZeneca

14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments

14.6 Sanofi

14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments

14.7 Eli Lilly and Co

14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments

14.8 F. Hoffmann-La Roche Ltd

14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments

14.9 Astellas Pharma Inc

14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments

14.10 Ipsen Pharma

14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments

15. Appendix

15.1 About Business Market Insights

15.2 List of Abbreviations

GCC Cancer Hormone Therapy Market (2021–2031)